The goal of this observational study is to learn about the relationship between serum Galectin-3 levels and subclinical inflammation in patients with Familial Mediterranean Fever (FMF). The main questions it aims to answer are: * Are serum Galectin-3 levels higher in FMF patients compared to healthy controls? * Is there a positive correlation between serum Galectin-3 levels and Serum Amyloid A (SAA) protein levels in FMF patients? Participants will: * Provide blood samples to measure serum Galectin-3 and SAA levels. * Complete a sociodemographic and clinical data form. * Fill out the FMF Quality of Life (QoL) scale. Researchers will compare FMF patients and healthy controls to see if there are significant differences in serum Galectin-3 levels and to determine the correlation between Galectin-3 and SAA protein levels in FMF patients.
Study Type
OBSERVATIONAL
Enrollment
154
Ataturk University Faculty of Medicine
Erzurum, Turkey (Türkiye)
Serum Galectin-3 Levels
Comparison of serum Galectin-3 levels between FMF patients and healthy controls to determine if there is a significant difference.
Time frame: 2022
Serum Amyloid A (SAA) Levels
Measurement of SAA levels in both FMF patients and healthy controls.
Time frame: 2022
Correlation Analysis
Determination of the correlation between serum Galectin-3 levels and SAA levels in FMF patients.
Time frame: 2022
Clinical Variables
Analysis of the relationship between Galectin-3/SAA levels and clinical variables such as age, BMI, disease duration, and frequency of FMF attacks.
Time frame: 2022
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.